Document is current
Any future updates will be listed below
-
Authors
Chirinos, Diana A.
Gurubhagavatula, Indira
Broderick, Preston
Chirinos, Julio A.
Teff, Karen
Wadden, Thomas
Maislin, Greg
Saif, Hassam
Chittams, Jesse
Cassidy, Caitlin
Hanlon, Alexandra L.
Pack, Allan I.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL080076)
- License Information
-
More Information
Article History
Received: 8 November 2016
Accepted: 16 June 2017
First Online: 21 June 2017
Compliance with ethical standards
:
: Julio A. Chirinos has received consulting fees from Bristol-Myers Squibb, OPKO Healthcare, Fukuda Denshi, Microsoft Research, Merck, and Vital Labs. Julio A. Chirinos received research grants from National Institutes of Health, American College of Radiology Network, Fukuda Denshi, Bristol-Myers Squibb, Microsoft Research and CVRx Inc, and device loans from Atcor Medical. He is named as inventor in a University of Pennsylvania patent application for the use of inorganic nitrates/nitrites for the treatment of Heart Failure and Preserved Ejection Fraction. Diana A. Chirinos, Indira Gurubhagavatula, Preston Broderick, Karen Teff, Thomas Wadden, Greg Maislin, Hassam Saif, Jesse Chittams, Caitlin Cassidy, Alexandra L. Hanlon, Allan I. Pack have no conflict of interest to disclose.
: All procedures followed were in accordance with ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
